Table 8 ICERs calculated for the imminent preterm birth models using cases of CP averted as the measure of effectiveness
From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Analysis | Method | Cost | Δ cost | Cases w/o CP | Δ cases w/o CP | ICER | Status |
|---|---|---|---|---|---|---|---|
Health system perspective | MgSO4 | $1,672 | -$653 | 0.95 | 0.02 | -$30,942 | Dominant |
No MgSO4 | $2,326 | 0.93 | |||||
Societal perspective | MgSO4 | $85,822 | -$32,808 | 0.95 | 0.02 | -$1,554,198 | Dominant |
No MgSO4 | $118,630 | 0.93 |